Skip to main content
Erschienen in: Clinical Oral Investigations 2/2014

01.03.2014 | Original Article

Association of MTHFR gene C677T mutation with recurrent aphthous stomatitis and number of oral ulcers

verfasst von: Goknur Kalkan, Nevin Karakus, Serbulent Yigit

Erschienen in: Clinical Oral Investigations | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Recurrent aphthous stomatitis (RAS) is a common ulcerative disease of the oral mucosa. Methylenetetrahydrofolate reductase (MTHFR) gene variants are associated with thrombophilia and vasculopathy that may result in oral ulceration. Oral ulcers are also the most common feature of Behcet’s disease (BD). Association of MTHFR gene C677T mutation with BD has been reported in different populations. The aim of the present study was to investigate the possible association between MTHFR gene C677T mutation and RAS and evaluate if there was an association with clinical features in a relatively large cohort of Turkish patients.

Materials and methods

The study included 188 patients affected by RAS and 200 healthy controls. Genomic DNA was isolated and genotyped using polymerase chain reaction (PCR)-based restriction fragment length polymorphism (RFLP) assay for the MTHFR gene C677T mutation.

Results

The genotype and allele frequencies of C677T mutation showed statistically significant differences between RAS patients and controls (p = 0.002 and p = 0.0004, respectively). After stratifying RAS patients according to clinical characteristics of oral ulcers, a significant association was observed between C677T mutation and number of oral ulcers of RAS patients (p = 0.006).

Conclusions

As a result, a high association between MTHFR gene C677T mutation and RAS was observed in the present study. Also number of oral ulcers was found to be associated with MTHFR C677T mutation in RAS patients.

Clinical Relevance

If our observation can be substantiated with further studies, evaluation for MTHFR mutations and perhaps folate supplementation may become necessary in selected patients.
Literatur
1.
Zurück zum Zitat Porter SR, Scully C, Pedersen A (1998) Recurrent aphthous stomatitis. Crit Rev Oral Biol Med 9:306–321PubMedCrossRef Porter SR, Scully C, Pedersen A (1998) Recurrent aphthous stomatitis. Crit Rev Oral Biol Med 9:306–321PubMedCrossRef
2.
Zurück zum Zitat Scully C, Porter S (2008) Oral mucosal disease: recurrent aphthous stomatitis. Br J Oral Maxillofac Surg 46:198–206PubMedCrossRef Scully C, Porter S (2008) Oral mucosal disease: recurrent aphthous stomatitis. Br J Oral Maxillofac Surg 46:198–206PubMedCrossRef
3.
Zurück zum Zitat Natah SS, Konttinen YT, Enattah NS, Ashammakhi N, Sharkey KA, Häyrinen-Immonen R (2004) Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg 33:221–234PubMedCrossRef Natah SS, Konttinen YT, Enattah NS, Ashammakhi N, Sharkey KA, Häyrinen-Immonen R (2004) Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg 33:221–234PubMedCrossRef
4.
Zurück zum Zitat Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S (1997) Epidemiological and clinical features of Behcet’s disease in Korea. Yonsei Med J 38:428–436PubMed Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S (1997) Epidemiological and clinical features of Behcet’s disease in Korea. Yonsei Med J 38:428–436PubMed
5.
Zurück zum Zitat Koubaa N, Hammami S, Nakbi A, Ben Hamda K, Mahjoub S, Kosaka T, Hammami M (2008) Relationship between thiolactonase activity and hyperhomocysteinemia according to MTHFR gene polymorphism in Tunisian Behçet's disease patients. Clin Chem Lab Med 46(2):187–192PubMedCrossRef Koubaa N, Hammami S, Nakbi A, Ben Hamda K, Mahjoub S, Kosaka T, Hammami M (2008) Relationship between thiolactonase activity and hyperhomocysteinemia according to MTHFR gene polymorphism in Tunisian Behçet's disease patients. Clin Chem Lab Med 46(2):187–192PubMedCrossRef
6.
Zurück zum Zitat Karakus N, Yigit S, Kalkan G, Rustemoglu A, Inanir A, Gul U, Pancar GS, Akkanet S, Ates O (2012) Association between the methylene tetrahydrofolate reductase gene C677T mutation and colchicine unresponsiveness in Behcet's disease. Mol Vis 18:1696–1700PubMedCentralPubMed Karakus N, Yigit S, Kalkan G, Rustemoglu A, Inanir A, Gul U, Pancar GS, Akkanet S, Ates O (2012) Association between the methylene tetrahydrofolate reductase gene C677T mutation and colchicine unresponsiveness in Behcet's disease. Mol Vis 18:1696–1700PubMedCentralPubMed
7.
Zurück zum Zitat Toffoli G, Russo A, Innocenti F, Corona G, Tumolo S, Sartor F, Mini E, Boiocchi M (2003) Effect of methylenetetrahydrofolate reductase 677CRT polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Int J Cancer 103:294–299PubMedCrossRef Toffoli G, Russo A, Innocenti F, Corona G, Tumolo S, Sartor F, Mini E, Boiocchi M (2003) Effect of methylenetetrahydrofolate reductase 677CRT polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Int J Cancer 103:294–299PubMedCrossRef
8.
Zurück zum Zitat Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113PubMedCrossRef Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113PubMedCrossRef
9.
10.
Zurück zum Zitat Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G (1988) Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43:414–421PubMedCentralPubMed Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G (1988) Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43:414–421PubMedCentralPubMed
11.
Zurück zum Zitat Rosendaal FR (1997) Risk factors for venous thrombosis: prevalence, risk, and interaction. Sem Hematol 34:171–177 Rosendaal FR (1997) Risk factors for venous thrombosis: prevalence, risk, and interaction. Sem Hematol 34:171–177
12.
Zurück zum Zitat Seshadri N, Homocysteine RK (2000) B vitamins and coronary artery disease. Med Clin North Am 84:215–217PubMedCrossRef Seshadri N, Homocysteine RK (2000) B vitamins and coronary artery disease. Med Clin North Am 84:215–217PubMedCrossRef
13.
Zurück zum Zitat Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M (2000) Recurrent aphthous stomatitis. Quintessence Int 31:95–112PubMed Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M (2000) Recurrent aphthous stomatitis. Quintessence Int 31:95–112PubMed
14.
Zurück zum Zitat Keijzer MB, Heijer M, Blom HJ, Bos GM, Willems HP, Gerrits WB, Rosendaal FR (2002) Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolate reductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 88:723–728PubMed Keijzer MB, Heijer M, Blom HJ, Bos GM, Willems HP, Gerrits WB, Rosendaal FR (2002) Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolate reductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 88:723–728PubMed
15.
Zurück zum Zitat Li XM, Wei YF, Hao YB, Hao YB, He LS, Li JD, Mei B, Wang SY, Wang C, Wang JX, Zhu JZ, Liang JQ (2002) Hyperhomocysteinemia and MTHFR mutation in Budd–Chiari syndrome. Am J Hematol 71:11–14PubMedCrossRef Li XM, Wei YF, Hao YB, Hao YB, He LS, Li JD, Mei B, Wang SY, Wang C, Wang JX, Zhu JZ, Liang JQ (2002) Hyperhomocysteinemia and MTHFR mutation in Budd–Chiari syndrome. Am J Hematol 71:11–14PubMedCrossRef
16.
Zurück zum Zitat Ehrenforth S, Nemes L, Mannhalter C, Rosendaal FR, Koder S, Zoghlami-Rintelen C, Scharrer I, Pabinger I (2004) Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V: G1691A. J Thromb Haemost 2:430–436PubMedCrossRef Ehrenforth S, Nemes L, Mannhalter C, Rosendaal FR, Koder S, Zoghlami-Rintelen C, Scharrer I, Pabinger I (2004) Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V: G1691A. J Thromb Haemost 2:430–436PubMedCrossRef
17.
Zurück zum Zitat Alpsoy E, Donmez L, Bacanli A, Apaydin C, Butun B (2003) Review of the chronology of clinical manifestations in 60 patients with Behcet’s disease. Dermatology 207:354–356PubMedCrossRef Alpsoy E, Donmez L, Bacanli A, Apaydin C, Butun B (2003) Review of the chronology of clinical manifestations in 60 patients with Behcet’s disease. Dermatology 207:354–356PubMedCrossRef
18.
Zurück zum Zitat Pipitone N, Boiardi L, Olivieri I, Cantini F, Salvi F, Malatesta R, La Corte R, Triolo G, Ferrante A, Filippini D, Paolazzi G, Sarzi-Puttini P, Restuccia G, Salvarani C (2004) Clinical manifestations of Behcet’s disease in 137 Italian patients: results of a multicenter study. Clin Exp Rheumatol 22(6 suppl 36):46–51 Pipitone N, Boiardi L, Olivieri I, Cantini F, Salvi F, Malatesta R, La Corte R, Triolo G, Ferrante A, Filippini D, Paolazzi G, Sarzi-Puttini P, Restuccia G, Salvarani C (2004) Clinical manifestations of Behcet’s disease in 137 Italian patients: results of a multicenter study. Clin Exp Rheumatol 22(6 suppl 36):46–51
19.
Zurück zum Zitat Wilcox GM, Mattia AR (2006) Celiac sprue, hyperhomocysteinemia, and MTHFR gene variants. J Clin Gastroenterol 40(7):596–601PubMedCrossRef Wilcox GM, Mattia AR (2006) Celiac sprue, hyperhomocysteinemia, and MTHFR gene variants. J Clin Gastroenterol 40(7):596–601PubMedCrossRef
20.
Zurück zum Zitat Dönmez G, Dönmez AD, Ozçakar L (2009) Do MTHFR mutations kick in during familial Mediterranean fever attacks? Acta Reumatol Port 34(3):561–562PubMed Dönmez G, Dönmez AD, Ozçakar L (2009) Do MTHFR mutations kick in during familial Mediterranean fever attacks? Acta Reumatol Port 34(3):561–562PubMed
21.
Zurück zum Zitat Oussalah A, Guéant JL, Peyrin-Biroulet L (2011) Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther 34(10):1173–1184PubMedCrossRef Oussalah A, Guéant JL, Peyrin-Biroulet L (2011) Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther 34(10):1173–1184PubMedCrossRef
22.
Zurück zum Zitat New D, Eaton P, Knable A, Callen JP (2011) The use of B vitamins for cutaneous ulcerations mimicking pyoderma gangrenosum in patients with MTHFR polymorphism. Arch Dermatol 147(4):450–453PubMedCrossRef New D, Eaton P, Knable A, Callen JP (2011) The use of B vitamins for cutaneous ulcerations mimicking pyoderma gangrenosum in patients with MTHFR polymorphism. Arch Dermatol 147(4):450–453PubMedCrossRef
23.
Zurück zum Zitat Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M (2003) DACH-LIGA Homocystein e.V. DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41:1392–1403PubMed Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M (2003) DACH-LIGA Homocystein e.V. DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41:1392–1403PubMed
24.
Zurück zum Zitat Fernandez-Banares F, Abad-Lacruz A, Xiol X, Gine JJ, Dolz C, Cabre E, Esteve M, Gonzalez-Huix F, Gassull MA (1989) Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 84:744–748PubMed Fernandez-Banares F, Abad-Lacruz A, Xiol X, Gine JJ, Dolz C, Cabre E, Esteve M, Gonzalez-Huix F, Gassull MA (1989) Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 84:744–748PubMed
25.
Zurück zum Zitat Saibeni S, Cattaneo M, Vecchi M, Zighetti ML, Lecchi A, Lombardi R, Meucci G, Spina L, de Franchis R (2003) Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol 98:112–117PubMedCrossRef Saibeni S, Cattaneo M, Vecchi M, Zighetti ML, Lecchi A, Lombardi R, Meucci G, Spina L, de Franchis R (2003) Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol 98:112–117PubMedCrossRef
26.
Zurück zum Zitat Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7–9PubMedCrossRef Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7–9PubMedCrossRef
Metadaten
Titel
Association of MTHFR gene C677T mutation with recurrent aphthous stomatitis and number of oral ulcers
verfasst von
Goknur Kalkan
Nevin Karakus
Serbulent Yigit
Publikationsdatum
01.03.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 2/2014
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-013-0997-0

Weitere Artikel der Ausgabe 2/2014

Clinical Oral Investigations 2/2014 Zur Ausgabe

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.